JUL 31, 2026 · REGULATORY LABEL UPDATE
FDA supplemental approval: Rosuvastatin Calcium (Labeling)
U.S. Food and Drug Administration
FDA supplemental approval of labeling changes for generic rosuvastatin calcium; does not contain clinical trial data or efficacy evidence.
Reported
Approval date2026-07-31
Dosage strengths approved5 mg, 10 mg, 20 mg, 40 mg